Home › Osteosarcoma › Florida › Tampa
Osteosarcoma clinical trials in Tampa, FL
6 studies for Osteosarcoma are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- St. Joseph's Children's Hospital, Tampa
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
RecruitingPhase 2
- St. Joseph's Children's Hospital, Tampa
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
RecruitingPhase 1/2
- Moffitt Cancer Center, Tampa
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- St. Joseph's Children's Hospital, Tampa
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Osteosarcoma trials in other cities
- St. Louis, MO10 studies
- Memphis, TN10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Houston, TX9 studies
- Birmingham, AL7 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Dallas, TX6 studies
- New York City, NY6 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer53 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Colorectal Cancer36 studies
- Lung Cancer31 studies
- Metastatic Cancer30 studies
- Acute Myeloid Leukemia30 studies
- Pancreatic Cancer26 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Alzheimer's Disease20 studies
- Myelodysplastic Syndromes20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.